Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00382109 · OUTCOME

Relative Contribution of ALL Blasts to the Donor Immune Response as a Cause of Relapse Post Transplantation (Correlating Development of aGVHD With Relapse)

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission · Source last updated 2019-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
Not reported
Time frame
At 1 year

What was measured

An event is defined as relapse; estimated probability of relapse.

Analysis population: Number at risk among no aGVHD and number at risk among aGVHD at 1 year. The two treatment regimens were intended to be analyzed together (combined data), as pre-specified in the study protocol, therefore results are not reported for each Arm of study.

Groups in this outcome

All Patients

Relative contribution of ALL blasts to the donor immune response as a cause of relapse post transplantation (correlating development of aGVHD with relapse).

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Patients67

Reported measurements

Experienced aGVHD, later relapsed

Analysis denominator · Participants

GroupSource count
All Patients35
Values in percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients5Not reportedNot reportedNot reportedNot reported
No aGVHD occurence, relapsed

Analysis denominator · Participants

GroupSource count
All Patients32
Values in percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients24Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        5
    denoms
    1. counts
      1. group Id
        OG000
        value
        35
      units
      Participants
    title
    Experienced aGVHD, later relapsed
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        24
    denoms
    1. counts
      1. group Id
        OG000
        value
        32
      units
      Participants
    title
    No aGVHD occurence, relapsed
denoms
  1. counts
    1. group Id
      OG000
      value
      67
    units
    Participants
description
An event is defined as relapse; estimated probability of relapse.
groups
  1. description
    Relative contribution of ALL blasts to the donor immune response as a cause of relapse post transplantation (correlating development of aGVHD with relapse).
    id
    OG000
    title
    All Patients
param Type
NUMBER
population Description
Number at risk among no aGVHD and number at risk among aGVHD at 1 year. The two treatment regimens were intended to be analyzed together (combined data), as pre-specified in the study protocol, therefore results are not reported for each Arm of study.
reporting Status
POSTED
time Frame
At 1 year
title
Relative Contribution of ALL Blasts to the Donor Immune Response as a Cause of Relapse Post Transplantation (Correlating Development of aGVHD With Relapse)
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice